Treating systemic fungal infections in AIDS patients

Preview

As the life expectancy of many immunocompromised patients improves, opportunistic fungal infections become more prominent as a cause of morbidity and mortality. Current therapeutic options are sometimes effective but limited by their toxicities. In this article, Dr Scheld discusses the oral antifungal agents that show promise in the treatment of these potentially devastating infections.